Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ZYMOGENETICS INC | 115,399 | reported | 08 Oct 2010 | tx 26+1,019,094−1,118,951 |
| Xencor Inc | 48,578 | reported | 14 Jun 2017 | tx 17+119,244−144,910 |
| QLT INC/BC | 45,000 | reported | 26 May 2011 | tx 7+65,000 |
| ENANTA PHARMACEUTICALS INC | 20,000 | reported | 11 Mar 2026 | tx 28+143,760−30,560 |
| Regulus Therapeutics Inc. | 17,500 | reported | 10 Jun 2015 | tx 9+90,000−85,000 |
| RENOVIS INC | 0 | reported | 02 May 2008 | tx 4+22,222−33,333 |
| Mirati Therapeutics, Inc. | 0 | reported | 23 Jan 2024 | tx 64+125,636−115,793 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 11 Mar 2026 | GRANT_AWARD | ENANTA PHARMACEUTICALS INC | 20,000 | 0.00 USD | deriv |
| 13 Mar 2025 | GRANT_AWARD | ENANTA PHARMACEUTICALS INC | 15,700 | 0.00 USD | deriv |
| 06 Mar 2024 | GRANT_AWARD | ENANTA PHARMACEUTICALS INC | 15,700 | 0.00 USD | deriv |
| 23 Jan 2024 | OTHER | Mirati Therapeutics, Inc. | 6,808 | — | |
| 23 Jan 2024 | OTHER | Mirati Therapeutics, Inc. | 4,444 | — | |
| 23 Jan 2024 | OTHER | Mirati Therapeutics, Inc. | 6,021 | — | |
| 23 Jan 2024 | OTHER | Mirati Therapeutics, Inc. | 7,520 | — | deriv |
| 23 Jan 2024 | OTHER | Mirati Therapeutics, Inc. | 10,000 | — | deriv |
| 23 Jan 2024 | OTHER | Mirati Therapeutics, Inc. | 11,000 | — | deriv |
| 29 Dec 2023 | GRANT_AWARD | Mirati Therapeutics, Inc. | 6,808 | 58.75 USD | |
| 02 Mar 2023 | GRANT_AWARD | ENANTA PHARMACEUTICALS INC | 10,800 | 0.00 USD | deriv |
| 20 Jan 2023 | GRANT_AWARD | Mirati Therapeutics, Inc. | 4,444 | 0.00 USD | |
| 20 Jan 2023 | GRANT_AWARD | Mirati Therapeutics, Inc. | 7,520 | 0.00 USD | deriv |
| 12 Aug 2022 | SALE | Mirati Therapeutics, Inc. | 5,107 | 85.04 USD | |
| 12 Aug 2022 | SALE | Mirati Therapeutics, Inc. | 4,893 | 85.96 USD | |
| 12 Aug 2022 | EXERCISE | Mirati Therapeutics, Inc. | 10,000 | 27.00 USD | |
| 12 Aug 2022 | EXERCISE | Mirati Therapeutics, Inc. | 10,000 | 0.00 USD | deriv |
| 21 Mar 2022 | SALE | ENANTA PHARMACEUTICALS INC | 307 | 67.23 USD | |
| 21 Mar 2022 | SALE | ENANTA PHARMACEUTICALS INC | 2,676 | 66.70 USD | |
| 21 Mar 2022 | EXERCISE | ENANTA PHARMACEUTICALS INC | 6,000 | 25.58 USD | |
| 21 Mar 2022 | SALE | ENANTA PHARMACEUTICALS INC | 2,210 | 68.66 USD | |
| 21 Mar 2022 | SALE | ENANTA PHARMACEUTICALS INC | 807 | 69.52 USD | |
| 21 Mar 2022 | EXERCISE | ENANTA PHARMACEUTICALS INC | 6,000 | 0.00 USD | deriv |
| 03 Mar 2022 | GRANT_AWARD | ENANTA PHARMACEUTICALS INC | 7,500 | 0.00 USD | deriv |
| 14 Jan 2022 | GRANT_AWARD | Mirati Therapeutics, Inc. | 2,546 | 0.00 USD |
1 purchase reported after at least 12 months of silence — most recent on 14 May 2009.